MARKETS
Markets

Adial Pharmaceuticals Says Stockholders Approve Conversion Of Series A Preferred Into 12,930,601 Shares, Raise Authorized Shares To 500,000,000 From 100,000,000

Oct 28, 2026 · 04:43 PM ET· updated 1h ago

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001513525/000121390026113337/ea0309977-8k_adial.htm

Share
Why It Matters

Adial stockholders voted to convert special shares into regular shares. This gives the company room to issue way more shares in the future.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.